Graham Shakes Up U.S. Biotech Panel

ITHACA, N.Y.—Two years after its creation, the Reagan administration’s policy council for coordinating biotechnology regulation faces an uncertain future. Presidential science adviser William Graham has decided to replace the Biotechnology Science Coordinating Committee (BSCC) with a group more directly under his control. Two weeks ago he told THE SCIENTIST that “BSCC has been suspended. it is no longer in operation.” A clause in the BSCC charter required review and

Written byYvonne Baskin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ITHACA, N.Y.—Two years after its creation, the Reagan administration’s policy council for coordinating biotechnology regulation faces an uncertain future.

Presidential science adviser William Graham has decided to replace the Biotechnology Science Coordinating Committee (BSCC) with a group more directly under his control. Two weeks ago he told THE SCIENTIST that “BSCC has been suspended. it is no longer in operation.”

A clause in the BSCC charter required review and renewal by Graham if the committee were to opeate beyond October 31.

Graham said in mid-October that he was “looking at various ways to reorganize” the BSCC and wanted “to broaden its scope to encompass all of biology and life sciences, not just environmental release and biotechnology.” Graham said that Beverly Berger, who joined the Office of Science and Technology Policy (OSTP) April 1 as his assistant director for life sciences, would “play a major role in whatever evolves.”

However, Berger ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies